Article
 

In Vivo Delivery of Morpholino Oligos by Cell-Penetrating Peptides

Public Deposited

Downloadable Content

Download PDF
https://ir.library.oregonstate.edu/concern/articles/p2677122v

Descriptions

Attribute NameValues
Creator
Abstract
  • Morpholino oligos (Morpholinos) are widely used tools for knocking down gene expression and are currently in a clinical trial for treatment of Duchene muscular dystrophy. A Morpholino analog has been in a clinical trial as a potential anti-bioterrorism agent for inhibiting replication of deadly Marburg viral infection. The cellular uptake of Morpholinos can been greatly increased by conjugation with cell-penetrating peptides (CPP). The use of the CPP-Morpholino conjugates (PPMOs) in vivo has been broadly demonstrated in viral, bacterial, genetic and other diseases. The following aspects of PPMOs will be discussed in this paper including chemistry, stability, antisense specificity, mechanism of cellular uptake, in vivo efficacy, tissue distribution, pharmacokinetics, toxicity and the human clinical trials. PPMOs are powerful research tools for studying gene function in animals and their properties are being improved as potential human therapeutic agents.
  • Keywords: Antisense, PPMO, Cell-penetrating peptide, Duchenne muscular dystrophy, Morpholino oligos
Resource Type
DOI
Date Available
Date Issued
Citation
  • Moulton, H. (2013). In vivo delivery of morpholino oligos by cell-penetrating peptides. Current Pharmaceutical Design, 19(16), 2963-2969.
Journal Title
Journal Volume
  • 19
Journal Issue/Number
  • 16
Academic Affiliation
Rights Statement
Publisher
Peer Reviewed
Language
Replaces

Relationships

Parents:

This work has no parents.

Items

Thumbnail Title Date Uploaded Visibility Actions
file details MoultonHongVeterinaryMedicineInVivoDeliveryMorpholino.pdf 2017-12-12 Public Download